Benznidazole Treatment Safety: The Médecins Sans Frontières Experience in a Large Cohort of Bolivian Patients with Chagas' Disease
Authors
Sperandio da Silva, GFelix Mediano, M
Hasslocher-Moreno, A
Holanda, M
Silvestre de Sousa, A
Sangenis, L
Brasil, P
Mejía, R
Fux, C
Cubides, J
Saraiva, R
Brum-Soares, L
Issue Date
2017-06-22Submitted date
2017-06-26
Metadata
Show full item recordAbstract
Up to half of patients with Chagas' disease under benznidazole treatment present adverse drug reactions (ADRs) and up to one-third do not complete standard treatment.PubMed ID
28645201Language
enDescription
We regret that this article is behind a paywall.ISSN
1460-2091ae974a485f413a2113503eed53cd6c53
10.1093/jac/dkx180
Scopus Count
Collections
Related articles
- Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
- Authors: Yun O, Lima MA, Ellman T, Chambi W, Castillo S, Flevaud L, Roddy P, Parreño F, Albajar Viñas P, Palma PP
- Issue date: 2009 Jul 7
- New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
- Authors: Álvarez MG, Hernández Y, Bertocchi G, Fernández M, Lococo B, Ramírez JC, Cura C, Albizu CL, Schijman A, Abril M, Sosa-Estani S, Viotti R
- Issue date: 2016 Feb
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
- Authors: Torrico F, Gascon J, Ortiz L, Alonso-Vega C, Pinazo MJ, Schijman A, Almeida IC, Alves F, Strub-Wourgaft N, Ribeiro I, E1224 Study Group.
- Issue date: 2018 Apr
- Safety of benznidazole use in the treatment of chronic Chagas' disease.
- Authors: Hasslocher-Moreno AM, do Brasil PE, de Sousa AS, Xavier SS, Chambela MC, Sperandio da Silva GM
- Issue date: 2012 May
- A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole.
- Authors: Sperandio da Silva GM, Mediano MF, Alvarenga Americano do Brasil PE, da Costa Chambela M, da Silva JA, de Sousa AS, Xavier SS, Rodrigues da Costa A, Magalhães Saraiva R, Hasslocher-Moreno AM
- Issue date: 2014 Nov